Ritter plans to price its IPO of 4 million shares at $5.00 per share

Company to sell its common stock through bookrunners Aegis and Chardan

By Devika Patel

Knoxville, Tenn., June 19 – Ritter Pharmaceuticals Inc. will sell 4 million common shares in its initial public offering with a 45-day greenshoe of 600,000 additional shares, according to a Form S-1/A filed Wednesday with the Securities and Exchange Commission. The company has registered $24 million of stock for the deal, which was announced June 4.

The stock will be sold at an expected price of $5.00 per share.

Aegis Capital Corp. and Chardan Capital Markets. LLC are the bookrunning managers, and Barrington Research Associates, Inc. is the co-manager.

The Research Triangle Park, N.C., pharmaceutical company develops therapeutics to treat kidney disease. The company’s expects its shares will trade on the Nasdaq under the symbol “RTTR.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.